Besides licensing its products to manufacturers, Intravacc also provides services. These services can include all phases of the vaccine development pathway, from lead to phase I-II clinical trials (one-stop-shop), or just one or more parts of it.
These services link our product development (R&D) services, analytical support, and manufacturing into one integrated process.
Intravacc designs and develops vaccines, improves the production processes of vaccines, and produces drug substances and products at cGMP-level to enable pre-clinical and clinical studies. Our leading principle in this is the Vaccine Development Pathway (VDP), which was fully implemented in 2020.
For the development of new vaccines, Intravacc uses established blueprints and scalable platform production processes. These are designed according to the regulatory requirements, using mathematical models, and are scalable from lab to high-volume production-scale bioreactors. Rationally designed processes and their products are tested in our state-of-the-art laboratory facilities using the latest ICH-guidelines and insights.
Quality, potency and safety are key features in the specification of biopharmaceutical drug substances and products. Therefore, choosing the right assays for determining the consistency of production and the quality of the produced vaccines is crucial.
Intravacc provides all aspects of vaccine-related assay development, assay validation, vaccine quality control and method transfer. Intravacc has a proven track record in establishing validated methods according to ICH guidelines for quality control of vaccines. Intravacc offers a wide range of analytical method development, characterization, validation, and analysis services.
A team of 100+ specialists is at your disposal here in Bilthoven. Contact us to see how we can bring your vaccine concept ready for in-human trials.
Stay up to date with the latest developments, and be the first to receive our news updates and announcements.
